They have known this for a very LONG time.
My guess is this post in face book will be taken down, even though nothing stated in it is false and all information can be found on line.
Virology Journal – the official publication of Dr. Fauci’s National Institutes of Health – published what is now a blockbuster article on August 22, 2005, under the heading – get ready for this – “Chloroquine is a potent inhibitor of SARS coronavirus infection and spread.” Writes the researchers, (Just so there are NO mistakes for the ‘fact checkers’ to dispute THESE ARE THE AUTHORS of this paper — DR. FAUCI DID NOT WRITE OR RESEARCH THE PAPER!)
Affiliations
Special Pathogens Brach, Division of Viral and Rickettsial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, 1600 Clifton Road, 30333, USA
Martin J Vincent, Bobbie R Erickson, Pierre E Rollin, Thomas G Ksiazek & Stuart T Nichol
Laboratory of Biochemical Neuroendocrinology, Clinical Research Institute of Montreal, Montreal, 110 Pine Ave West, QCH2W1R7, Canada
Eric Bergeron, Suzanne Benjannet & Nabil G Seidah
Corresponding author : Correspondence to Stuart T Nichol.
Additional information
Competing interests
The author(s) declare that they have no competing interests.
Authors’ contributions
MV did all the experiments pertaining to SARS CoV infection and coordinated the drafting of the manuscript. EB and SB performed experiments on ACE2 biosynthesis and FACS analysis. BE performed data acquisition from the immunofluorescence experiments. PR and TK provided critical reagents and revised the manuscript critically. NS and SN along with MV and EB participated in the planning of the experiments, review and interpretation of data and critical review of the manuscript. All authors read and approved the content of the manuscript.
“We report…that chloroquine has strong antiviral effects on SARS-CoV infection of primate cells. These inhibitory effects are observed when the cells are treated with the drug either before or after exposure to the virus, suggesting both prophylactic and therapeutic advantage.”
https://www.orlandomedicalnews.com/article/3397/opinion-letter-from-the-publisher
AND JUST SO THAT WE ARE CLEAR ABOUT THIS POINT:
DR FAUCI IS CURRENTLY THE DIRECTOR OF THE NATIONAL INSTITUTE OF HEALTH, NIH.
About NIAID Director, Anthony Fauci, M.D.
Previous Directors
Current Director
Anthony S. Fauci, M.D.
Director 1984–Present
https://www.niaid.nih.gov/about/directors
AND FOR YOUR EDIFICATION HERE ARE THE FIRST THREE PARAGRAPHS OF THE ABSTRACT FROM THE JOURNAL PUBLICATION.
See the link at the bottom of the article for further reading.
Research
Open Access
Published: 22 August 2005
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
Martin J Vincent, Eric Bergeron, Suzanne Benjannet, Bobbie R Erickson, Pierre E Rollin, Thomas G Ksiazek, Nabil G Seidah & Stuart T Nichol
Virology Journal volume 2, Article number: 69 (2005) Cite this article
718k Accesses
380 Citations
43670 Altmetric
Metrics details
Abstract
Background
Severe acute respiratory syndrome (SARS) is caused by a newly discovered coronavirus (SARS-CoV). No effective prophylactic or post-exposure therapy is currently available.
Results
We report, however, that chloroquine has strong antiviral effects on SARS-CoV infection of primate cells. These inhibitory effects are observed when the cells are treated with the drug either before or after exposure to the virus, suggesting both prophylactic and therapeutic advantage. In addition to the well-known functions of chloroquine such as elevations of endosomal pH, the drug appears to interfere with terminal glycosylation of the cellular receptor, angiotensin-converting enzyme 2. This may negatively influence the virus-receptor binding and abrogate the infection, with further ramifications by the elevation of vesicular pH, resulting in the inhibition of infection and spread of SARS CoV at clinically admissible concentrations.
Conclusion
Chloroquine is effective in preventing the spread of SARS CoV in cell culture. Favorable inhibition of virus spread was observed when the cells were either treated with chloroquine prior to or after SARS CoV infection. In addition, the indirect immunofluorescence assay described herein represents a simple and rapid method for screening SARS-CoV antiviral compounds.
https://virologyj.biomedcentral.com/articles/10.1186/1743-422X-2-69
In the Mind's Eye 
One thought on “Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. August 22, 2005”